trending Market Intelligence /marketintelligence/en/news-insights/trending/osj5d7aj1edc-fl_iuhizq2 content esgSubNav
In This List

Cancer Genetics CEO to step down

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Cancer Genetics CEO to step down

Panna Sharma is stepping down as president, CEO and a director of Cancer Genetics Inc.

John Roberts, Cancer Genetics' COO, will serve as interim CEO. Sharma will provide consulting services to the company to assist in the transition.

Roberts has been the COO of the Rutherford, N.J.-based company since July 2016.

Cancer Genetics offers a range of laboratory services that provide genomic and biomarker information to develop precision medicine.